Ikapharmindo Putramas Tbk PT
IDX:IKPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ikapharmindo Putramas Tbk PT
IDX:IKPM
|
ID |
Balance Sheet
Balance Sheet Decomposition
Ikapharmindo Putramas Tbk PT
Ikapharmindo Putramas Tbk PT
Balance Sheet
Ikapharmindo Putramas Tbk PT
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
20 823
|
14 309
|
10 883
|
44 294
|
23 830
|
|
| Cash |
20 823
|
14 309
|
10 883
|
44 294
|
23 830
|
|
| Total Receivables |
200 675
|
153 547
|
171 731
|
200 501
|
256 521
|
|
| Accounts Receivables |
179 048
|
150 394
|
170 735
|
200 364
|
256 358
|
|
| Other Receivables |
21 627
|
3 152
|
996
|
138
|
163
|
|
| Inventory |
174 960
|
53 759
|
79 284
|
56 009
|
51 763
|
|
| Other Current Assets |
12 856
|
5 894
|
6 902
|
7 280
|
5 090
|
|
| Total Current Assets |
409 314
|
227 508
|
268 799
|
308 084
|
337 204
|
|
| PP&E Net |
139 776
|
82 296
|
78 214
|
113 502
|
108 923
|
|
| Intangible Assets |
13 749
|
13 882
|
14 275
|
14 354
|
14 573
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
2 148
|
|
| Long-Term Investments |
0
|
57 569
|
22 156
|
22 156
|
22 156
|
|
| Other Long-Term Assets |
14 206
|
3 798
|
4 108
|
5 281
|
6 373
|
|
| Total Assets |
577 044
N/A
|
385 053
-33%
|
387 553
+1%
|
463 377
+20%
|
491 378
+6%
|
|
| Liabilities | ||||||
| Accounts Payable |
33 677
|
27 826
|
42 495
|
36 853
|
41 528
|
|
| Accrued Liabilities |
6 219
|
2 726
|
3 625
|
3 723
|
1 865
|
|
| Short-Term Debt |
238 091
|
136 000
|
143 809
|
149 400
|
170 989
|
|
| Current Portion of Long-Term Debt |
4 749
|
2 348
|
425
|
0
|
0
|
|
| Other Current Liabilities |
5 200
|
4 361
|
3 102
|
6 198
|
6 374
|
|
| Total Current Liabilities |
287 936
|
173 261
|
193 456
|
196 174
|
220 756
|
|
| Long-Term Debt |
3 239
|
425
|
0
|
0
|
0
|
|
| Minority Interest |
1 769
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
26 124
|
15 652
|
17 399
|
22 491
|
24 497
|
|
| Total Liabilities |
319 067
N/A
|
189 338
-41%
|
210 855
+11%
|
218 665
+4%
|
245 253
+12%
|
|
| Equity | ||||||
| Common Stock |
100 000
|
100 000
|
100 000
|
168 466
|
168 466
|
|
| Retained Earnings |
144 387
|
82 832
|
63 798
|
44 363
|
45 587
|
|
| Additional Paid In Capital |
3 538
|
350
|
350
|
19 089
|
19 089
|
|
| Other Equity |
10 052
|
12 534
|
12 550
|
12 794
|
12 982
|
|
| Total Equity |
257 978
N/A
|
195 716
-24%
|
176 698
-10%
|
244 712
+38%
|
246 125
+1%
|
|
| Total Liabilities & Equity |
577 044
N/A
|
385 053
-33%
|
387 553
+1%
|
463 377
+20%
|
491 378
+6%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
1 685
|
1 685
|
1 685
|
1 685
|
1 685
|
|